🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on the fourteenth of October at age 51 after a personal fight with pancreatic malignancy.

“The brilliant light of our family has faded away for us in this life,” his relatives confirmed. “After a lengthy and brave battle with the disease, we are heartbroken to announce that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative modern soul style and partnerships with renowned musicians.

He released his first record, “Brown Sugar,” in the mid-nineties to instant praise. The record reached No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his music career into the limelight. The record premiered at No. 1 on both the R&B charts and the main album chart. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal featured the artist, famously bare to his midsection, performing directly into the lens.

D’Angelo stepped back from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious car crash that put him in critical condition.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with a further No. 1 debut on the soul music rankings and a Grammy for Best R&B Album.

Once more, in his own mysterious way, D’Angelo had limited public appearances in the following years.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s health in the months before his passing, he had apparently been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable forms of the illness, on a gifted artist whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his loved ones, but we are eternally grateful for the legacy of deeply emotional songs he has left us,” his family said.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a tiny gland that generates insulin and is vital in breaking down food, among additional roles. The size and location of the organ in the human system make it more difficult to identify cancer.

Although pancreatic cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is responsible for 7% of cancer deaths.

Nearly 70,000 people will be diagnosed with this condition and roughly 52,000 will succumb to the illness in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have limited and ineffective therapies, and a smaller window to make a meaningful impact on the lives of patients,” noted a cancer specialist.

Because this disease seldom produces initial signs, it’s often identified only once the condition is late-stage. Even when a individual has indicators they are often vague and may be mistaken for a several common illnesses.

“Currently, there is no good way to identify pancreatic cancer in the early stages, except for listening to your body and consulting your doctor if there are unfamiliar symptoms,” said a health expert.

Frequent indicators of this disease include:

• abdominal or lower back pain
• weight loss
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as this malignancy is typically found in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become more common in younger people.

“This disease identified before the age of 50 is deemed uncommon, yet concerningly, clinicians are noticing a growing number of younger individuals affected by this disease,” said a expert.

Genetic Background Affects Cancer Risk

In the absence of effective screening tools for pancreatic cancer, experts stressed the significance of knowing your family’s health background. Certain contributing elements, such as tobacco use and excess weight also play a role in the development of pancreatic cancer.

Black individuals have the greatest occurrence of this malignancy in the United States and are most likely to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s chance of pancreatic cancer is understanding personal risk factors. People should examine their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their vulnerability,” advised a medical professional.

Inherited genetic elements are associated with as much as 10% of all pancreatic cancer instances. If a relative in your household has had this disease, you may want to consider genetic testing.

“For individuals with a relative’s background of this condition or those having elevated risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect early changes in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may have an effect. The best action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Excessive drinking is associated with pancreatitis, a risk factor for this malignancy, so reducing or abstaining from drinks may assist reduce your risk.

Managing your weight or losing weight may also help decrease your susceptibility. People with excess weight are twenty percent more prone to get pancreatic cancer. This malignancy also is more frequent in people with blood sugar issues, and weight loss can also lower the risk of type 2 diabetes.

Despite this disease’s grim outlook, there is reason for optimism.

“We are doing better with therapies and newer mixed drug treatments. There are emerging targeted therapies that already are making an impact,” remarked a specialist.

For numerous people, however, awareness about this uncommon but {dev